Journey Medical Corporation
DERM
$5.29
-$0.02-0.38%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.63M | 14.86M | 13.03M | 15.26M | 15.28M |
| Total Other Revenue | -- | -- | -- | 0.00 | 19.26M |
| Total Revenue | 14.63M | 14.86M | 13.03M | 15.26M | 34.54M |
| Cost of Revenue | 5.29M | 6.54M | 6.82M | 6.02M | 6.43M |
| Gross Profit | 9.34M | 8.31M | 6.21M | 9.24M | 28.11M |
| SG&A Expenses | 11.40M | 10.33M | 8.42M | 9.84M | 8.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.52M | 17.78M | 23.12M | 17.36M | 17.29M |
| Operating Income | -2.89M | -2.93M | -10.09M | -2.10M | 17.25M |
| Income Before Tax | -2.39M | -3.36M | -10.44M | -2.02M | 16.88M |
| Income Tax Expenses | -- | -- | -- | 126.00K | 95.00K |
| Earnings from Continuing Operations | -2.39M | -3.36M | -10.44M | -2.14M | 16.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.39M | -3.36M | -10.44M | -2.14M | 16.79M |
| EBIT | -2.89M | -2.93M | -10.09M | -2.10M | 17.25M |
| EBITDA | -2.08M | -2.11M | -9.28M | -1.29M | 18.06M |
| EPS Basic | -0.12 | -0.17 | -0.53 | -0.11 | 0.91 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.33 | -0.07 | 0.57 |
| EPS Diluted | -0.12 | -0.17 | -0.53 | -0.12 | 0.80 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.33 | -0.07 | 0.50 |
| Average Basic Shares Outstanding | 20.54M | 19.99M | 19.76M | 18.69M | 18.42M |
| Average Diluted Shares Outstanding | 20.54M | 19.99M | 19.76M | 18.69M | 21.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
